An international team led by Wolf Hervé Fridman with researchers from Inserm, Sorbonne Université and Université de Paris at the Cordeliers Research Center, in collaboration with the French League against cancer and Institut Bergonié, has shown that B cells also play a major role in predicting of patient’s response to immunotherapy. It was previously thought only T cells could be used in this way.
PREVAC-UP: The Partnership for Research on Ebola Vaccination extends follow-up and builds research capacity against deadly disease
Bonne année 2020!
For sociologists, our individual memories are shaped by the collective memory of our community. Until this new study, this phenomenon had never been studied at the neurobiological level.
Could atmospheric pollutants have an impact on proper menstrual cycle function? This was the question asked by a research group led by Inserm researcher Rémy Slama at the Institute for Advanced Biosciences (Inserm/CNRS /Université Grenoble Alpes).
Using cerebral imaging, connections between the various brain regions can be visualized. These connections form a veritable "map" of its structure, specific to each individual. Knowledge of these "maps" is enough to predict not just brain function but also the potential development and treatment of neurological diseases.
In animals, a vaccine modifying the composition and function of the gut microbiota provides protection against the onset of chronic inflammatory bowel diseases and certain metabolic disorders, such as diabetes and obesity.
Inserm has published a new Collective Expert Review, this time looking at developmental coordination disorder (DCD) – otherwise known as dyspraxia.
Teams from Dijon-Bourgogne University Hospital, Inserm and CEA have recently established the results of the whole-genome analysis of severely ill neonates, hospitalized in neonatal ICUs – the time of which was slashed from the current 18-month average to just 38 days.
Circulating tumor cells use the blood and lymphatic networks to disseminate within the body, forming metastases distant from the primary tumor. Inserm researcher Jacky Goetz and his Tumor Biomechanics team at the Molecular ImmunoRheumatology laboratory (Inserm/Université de Strasbourg) have helped to show that the flow properties of these biological fluids have a huge influence on the risk of developing metastases.